H.R. 5343 House Health
Ensuring Patient Access to Critical Breakthrough Products Act
STAGE 2 OF 8 — COMMITTEE CONSIDERATION
Currently in the House. Last action: ordered to be reported in the nature of a substitute (amended) by the yeas and nays: 37 - 3 on Sep 17, 2025.
- House Introduced in House Sep 15, 2025
- House Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. Sep 15, 2025
- House Committee Consideration and Mark-up Session Held Sep 17, 2025
- House Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3. Sep 17, 2025
Cosponsors
51
Subjects
Congressional oversightDrug safety, medical device, and laboratory regulationHealth care costs and insuranceHealth care coverage and accessHealth programs administration and fundingHealth technology, devices, suppliesMedicare
Committees
- Ways and Means Committee
- Markup By , Sep 17, 2025
- Referred To , Sep 15, 2025
- Energy and Commerce Committee
- Referred To , Sep 15, 2025
Summary
No summary available.
Comments · 0
Please log in to post a comment.
Loading comments...